https://www.scmp.com/rss/7/feed Updated share price information on listed securities en https://assets-v2.i-scmp.com/production/static/img/icons/scmp-meta-1200x630.png https://www.scmp.com Yulu Ao Yulu Ao China Asset Management (Hong Kong), the offshore arm of one of mainland China’s largest asset managers, launched three exchange-traded funds (ETFs) in the city on Thursday, expanding its product line-up as investors seek more diversified strategies amid market volatility and a broader boom in the ETF market. The three products – a Hong Kong high-dividend ETF, a Hong Kong growth ETF and a Hong Kong-US “Halo” ETF – are scheduled to list on the Hong Kong stock exchange on September 30, with trading... https://www.scmp.com/business/china-business/article/3368617/chinaamc-launches-3-hong-kong-etfs-demand-targeted-strategies-grows?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3368617/chinaamc-launches-3-hong-kong-etfs-demand-targeted-strategies-grows?utm_source=rss_feed Thu, 24 Sep 2026 07:00:36 +0000 Yulu Ao Yulu Ao Young Chinese investors may be just as willing to take risks as their global peers, but their portfolios remain more conservative against a backdrop of years of relative underperformance in China’s stock market, a prolonged property downturn and deflation, according to a senior researcher at the CFA Institute Research and Policy Centre. The disconnect between their willingness to take risks and their actual investment choices illustrated what the institute called an “aspiration-implementation... https://www.scmp.com/business/china-business/article/3367220/chinas-young-investors-embrace-risk-so-why-are-their-portfolios-so-safe?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3367220/chinas-young-investors-embrace-risk-so-why-are-their-portfolios-so-safe?utm_source=rss_feed Fri, 11 Sep 2026 10:05:57 +0000 Yulu Ao Yulu Ao Shenzhen, the southern Chinese city home to US-sanctioned telecoms giant Huawei Technologies and drone maker DJI, has seen an influx of investors and business leaders amid rising global interest in Chinese artificial intelligence and robotics. On Tuesday, the tech hub hosted investor conferences led by three international financial institutions – HSBC, UBS and Nomura – with AI, robotics and other emerging technologies featuring prominently on their agendas. More investors could arrive to chase... https://www.scmp.com/business/china-business/article/3365965/global-investors-descend-chinas-shenzhen-ride-wave-ai-and-robotics-opportunities?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3365965/global-investors-descend-chinas-shenzhen-ride-wave-ai-and-robotics-opportunities?utm_source=rss_feed Tue, 01 Sep 2026 09:00:09 +0000 Yulu Ao Yulu Ao WuXi Biologics, one of China’s largest contract drug developers, posted a 4.3 per cent increase in profit attributable to shareholders in the first half of the year, as stronger demand and improved capacity utilisation lifted revenue and margins. The Wuxi, Jiangsu-based company’s net profit attributable to shareholders rose to 2.44 billion yuan (US$363 million) in the six months ended June, according to its filing to the Hong Kong stock exchange on Tuesday. Revenue increased 18.4 per cent to... https://www.scmp.com/business/china-business/article/3365237/wuxi-biologics-posts-43-rise-first-half-profit-defying-biotech-headwinds?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3365237/wuxi-biologics-posts-43-rise-first-half-profit-defying-biotech-headwinds?utm_source=rss_feed Tue, 25 Aug 2026 13:03:49 +0000 Zoe SL Chan Zoe SL Chan Fast-fashion retailer Shein Global Holdings is seeking to raise as much as HK$13.85 billion (US$1.76 billion) in a Hong Kong initial public offering that was initially planned four years ago. Shein will sell 279 million shares at HK$47.60 to HK$49.50 each, according to a filing to the city’s stock exchange on Monday. The company began taking investor orders on Monday, with trading expected to start on September 1. Cornerstone investors – who will get guaranteed allocations in exchange for... https://www.scmp.com/business/markets/article/3365001/shein-seeks-raise-us176-billion-hong-kong-initial-public-offering?utm_source=rss_feed https://www.scmp.com/business/markets/article/3365001/shein-seeks-raise-us176-billion-hong-kong-initial-public-offering?utm_source=rss_feed Mon, 24 Aug 2026 01:24:52 +0000 Ann Cao Ann Cao China’s top two contract chipmakers, Semiconductor Manufacturing International Corporation (SMIC) and Hua Hong Grace Semiconductor, saw their profits surge by triple digits in the second quarter, amid a spike in demand for domestic artificial intelligence chips free of US export controls. Net profits for SMIC and Hua Hong jumped 261.7 per cent and 385.9 per cent year on year to US$479.2 million and US$38.6 million, respectively, in the June quarter. SMIC, the country’s largest foundry, said... https://www.scmp.com/tech/tech-trends/article/3363929/ai-demand-drives-triple-digit-quarterly-profit-growth-chinese-foundries-smic-hua-hong?utm_source=rss_feed https://www.scmp.com/tech/tech-trends/article/3363929/ai-demand-drives-triple-digit-quarterly-profit-growth-chinese-foundries-smic-hua-hong?utm_source=rss_feed Thu, 13 Aug 2026 11:00:10 +0000 Cheryl Arcibal Cheryl Arcibal CK Hutchison Holdings, one of the flagship companies owned by Hong Kong billionaire Li Ka-shing’s family, reported a 3,046 per cent increase in its first-half profit amid a period the firm’s chairman called “turbulent and uncertain”. Meanwhile, CK Asset Holdings, the group’s other flagship company that focuses on residential and commercial property, registered a 37.8 per cent jump in net profit during the same period. CK Hutchison, the port-to-telecoms conglomerate, said on Thursday that its... https://www.scmp.com/business/china-business/article/3363924/ck-hutchison-holdings-reports-31-fold-surge-first-half-profit?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3363924/ck-hutchison-holdings-reports-31-fold-surge-first-half-profit?utm_source=rss_feed Thu, 13 Aug 2026 09:59:17 +0000 Iris Deng Iris Deng China’s upstream supply chain for multilayer ceramic capacitors (MLCCs) – tiny components dubbed “the rice of electronics” – is racing to expand capacity, as an artificial intelligence-driven boom triggers a surge in global orders. Shandong Sinocera Functional Materials, a major supplier of dielectric powder to MLCC manufacturers, told investors in a Shenzhen Stock Exchange filing on Wednesday that it was actively pushing to expand capacity for AI servers and vehicles, with parts of its new... https://www.scmp.com/tech/tech-trends/article/3363190/chinas-mlcc-supply-chain-expanding-rapidly-amid-surge-global-ai-demand?utm_source=rss_feed https://www.scmp.com/tech/tech-trends/article/3363190/chinas-mlcc-supply-chain-expanding-rapidly-amid-surge-global-ai-demand?utm_source=rss_feed Thu, 06 Aug 2026 11:30:08 +0000 Howard Liu Howard Liu The three independent spin-offs of Chinese fintech giant Ant Group are accelerating their capital-raising efforts, forging distinct financial paths after gaining operational autonomy in 2024. Ant Digital Technologies is preparing a financing round ahead of its initial public offering, according to Chinese financial news outlet STAR Market Daily, marking the latest strategic move from one of the units that it spun off. Details regarding the round’s valuation, target size, timeline or planned... https://www.scmp.com/tech/big-tech/article/3362420/ant-group-spin-offs-pursue-independent-growth-strategic-capital-moves?utm_source=rss_feed https://www.scmp.com/tech/big-tech/article/3362420/ant-group-spin-offs-pursue-independent-growth-strategic-capital-moves?utm_source=rss_feed Thu, 30 Jul 2026 11:39:36 +0000 Enoch Yiu Enoch Yiu Standard Chartered shares rose 3.9 per cent to HK$231.40 on Wednesday after the bank announced strong first-half results and a US$1 billion share buy-back programme. The London-headquartered lender reported a 10 per cent rise in its first-half profit as strong wealth management gains were offset by an impairment charge tied to the Middle East conflict. The US$1 billion share buy-back will start immediately, according to a stock exchange filing on Wednesday. Net profit climbed 10 per cent in the... https://www.scmp.com/business/banking-finance/article/3362209/standard-chartered-posts-10-rise-first-half-profit-launches-us1b-buy-back?utm_source=rss_feed https://www.scmp.com/business/banking-finance/article/3362209/standard-chartered-posts-10-rise-first-half-profit-launches-us1b-buy-back?utm_source=rss_feed Wed, 29 Jul 2026 04:28:12 +0000 Wency Chen Wency Chen ChangXin Memory Technologies (CXMT) and Zhipu AI have not only seen their share prices skyrocket, but they have also handed a windfall to their common backer: Alibaba Group Holding. Before the listing of China’s memory-chip giant on Monday, Alibaba owned nearly 5 per cent of CXMT, making it the chipmaker’s largest industrial shareholder, according to the prospectus. Alibaba has invested about 7.6 billion yuan in CXMT since 2021. Based on Tuesday’s closing market capitalisation of about 3.14... https://www.scmp.com/tech/tech-trends/article/3362156/cxmt-zhipu-how-alibabas-investment-pays-growing-ai-and-chip-portfolio?utm_source=rss_feed https://www.scmp.com/tech/tech-trends/article/3362156/cxmt-zhipu-how-alibabas-investment-pays-growing-ai-and-chip-portfolio?utm_source=rss_feed Tue, 28 Jul 2026 13:30:06 +0000 Julie Zhang Julie Zhang China’s drug regulator has for the first time approved a novel, globally tested medicine ahead of authorities in the United States, Japan and Europe, marking a “historic breakthrough” as the country doubles down on biopharmaceuticals as one of its growth engines. The drug was filed for market approval in multiple countries, and “China was the first in the world to approve it”, said Xu Xiaoqiang, head of chemical drugs registration at the National Medical Products Administration (NMPA), in an... https://www.scmp.com/business/china-business/article/3361359/whats-stake-beijing-beats-global-peers-first-approval-novel-therapy?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3361359/whats-stake-beijing-beats-global-peers-first-approval-novel-therapy?utm_source=rss_feed Tue, 21 Jul 2026 23:00:11 +0000 Julie Zhang Julie Zhang A US-headquartered biotech firm plans to seek a primary listing in Hong Kong, joining a swelling pipeline of artificial intelligence-powered medical players raising capital in the city. Axiom Biosciences, which develops experimental therapies for newborns with severe brain injuries by using AI, is targeting at least US$200 million through an initial public offering (IPO) in Hong Kong in 2027, followed by a secondary listing in the US in 2029. “Some of the most important science in the world is... https://www.scmp.com/business/banking-finance/article/3361283/us-biotech-firm-developing-therapies-infant-brain-injuries-plans-hong-kong-listing?utm_source=rss_feed https://www.scmp.com/business/banking-finance/article/3361283/us-biotech-firm-developing-therapies-infant-brain-injuries-plans-hong-kong-listing?utm_source=rss_feed Tue, 21 Jul 2026 11:00:09 +0000 Howard Liu Howard Liu As soon as ChangXin Memory Technologies opened its blockbuster initial public offering to public subscription on Thursday morning, Luo Yi applied for 86,000 shares – despite acknowledging that she knew little about the semiconductor industry. The 60-year-old stock investor from southwestern Sichuan province was encouraged by her securities account manager, who told her that CXMT’s unusually large share sale could produce a higher allotment rate than most Chinese mainland IPOs. Luo’s application... https://www.scmp.com/tech/article/3360822/cxmts-mega-ipo-draws-frenzy-retail-investors-deepseek-founders-fund?utm_source=rss_feed https://www.scmp.com/tech/article/3360822/cxmts-mega-ipo-draws-frenzy-retail-investors-deepseek-founders-fund?utm_source=rss_feed Thu, 16 Jul 2026 12:00:06 +0000 Julie Zhang Julie Zhang Facing anti-corruption policies and profit squeezing at home, Chinese innovative medical device companies are accelerating their push into the European market despite mounting cross-border trade protectionism. Government-backed hospital purchases of medical devices in China fell about 12 per cent year on year in the first five months of 2026, partly weighed down by “a new anti-corruption probe into hospitals”, dragging on the revenue of major Chinese medical device makers in the first half, said... https://www.scmp.com/business/china-business/article/3360420/chinese-medical-device-makers-push-europe-anti-corruption-squeeze-bites-home?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3360420/chinese-medical-device-makers-push-europe-anti-corruption-squeeze-bites-home?utm_source=rss_feed Tue, 14 Jul 2026 01:00:27 +0000 Julie Zhang Julie Zhang After China’s cross-border deals for innovative drugs hit a record US$110 billion in the first half of 2026, the sector is now pivoting towards artificial intelligence-powered candidates to drive the next wave of transactions. China accounted for about 30 per cent of all new drugs currently under development worldwide, ranking second globally, according to Lan Gongtao, deputy director general of the Department of Drug Registration at the National Medical Products Administration. China’s... https://www.scmp.com/business/china-business/article/3360395/chinas-drug-industry-pivots-ai-powered-candidates-drive-next-wave-deals?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3360395/chinas-drug-industry-pivots-ai-powered-candidates-drive-next-wave-deals?utm_source=rss_feed Mon, 13 Jul 2026 10:15:09 +0000 Julie Zhang Julie Zhang The Hong Kong stock exchange is drawing a growing number of foreign companies from across Asia and North America that are seeking international capital, as the bourse marks progress in its ambition to be a global magnet for fundraising. The latest firm seeking to join the cohort is Kazakhstan Temir Zholy, the Central Asian nation’s railway operator and owner of the country’s largest fleet of locomotives and rolling stock, which filed for a Hong Kong listing on June 30, according to bourse... https://www.scmp.com/business/banking-finance/article/3360049/hong-kong-exchange-marks-progress-luring-more-listings-abroad?utm_source=rss_feed https://www.scmp.com/business/banking-finance/article/3360049/hong-kong-exchange-marks-progress-luring-more-listings-abroad?utm_source=rss_feed Fri, 10 Jul 2026 02:30:07 +0000 Daisy Wu Daisy Wu China’s artificial intelligence stocks entered the second half of 2026 with improving earnings momentum, but first-half results and high-profile bearish positioning by US investors regarding the global AI trade have begun to weigh on sentiment. “It is only a matter of time now,” said Michael Burry, the US hedge fund manager, in a post on Substack on Tuesday. Burry, who famously shorted the American housing market before the 2008 financial crisis and whose story was later popularised in the 2015... https://www.scmp.com/business/china-business/article/3359195/chinas-ai-stocks-surge-65-first-half-bubble-fears-begin-weigh-sentiment?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3359195/chinas-ai-stocks-surge-65-first-half-bubble-fears-begin-weigh-sentiment?utm_source=rss_feed Fri, 03 Jul 2026 00:00:09 +0000 Julie Zhang Julie Zhang China’s anti-tax evasion campaign is sweeping across the A-share and Hong Kong stock markets, with at least 80 listed firms already having been ordered to pay back corporate income taxes and late fees to local authorities. The number of listed companies involved in the first half of the year is likely to soon surpass the total of 89 for full-year 2025, raising concerns that Beijing’s taxation drive could be extended amid local debt black holes, which would threaten corporate earnings, cash flows... https://www.scmp.com/economy/article/3359042/chinas-tax-crackdown-shakes-share-and-hong-kong-listed-firms-major-payouts?utm_source=rss_feed https://www.scmp.com/economy/article/3359042/chinas-tax-crackdown-shakes-share-and-hong-kong-listed-firms-major-payouts?utm_source=rss_feed Thu, 02 Jul 2026 02:00:16 +0000 Julie Zhang Julie Zhang Hong Kong has surrendered its IPO fundraising crown to Nasdaq following SpaceX’s blockbuster listing earlier this month, but it did so while seeing its IPO proceeds register a year-on-year rise of about 84 per cent in the first half of 2026 – consolidating the region’s position as a primary offshore financial hub for Chinese issuers. A total of 83 companies raised US$26.42 billion on the Hong Kong stock exchange’s main board from January to June, according to LSEG Data & Analytics. The figure,... https://www.scmp.com/business/banking-finance/article/3358823/hong-kong-ipos-ride-chinas-tech-wave-nasdaq-leads-way-spacex-tsunami?utm_source=rss_feed https://www.scmp.com/business/banking-finance/article/3358823/hong-kong-ipos-ride-chinas-tech-wave-nasdaq-leads-way-spacex-tsunami?utm_source=rss_feed Tue, 30 Jun 2026 02:00:09 +0000 Julie Zhang Julie Zhang Hong Kong is seizing every opportunity to consolidate its role as a global financial centre, leveraging unique advantages and national strategies. This piece, the second in a miniseries focusing on the city’s financial industry ahead of the handover anniversary, explores the likelihood of an “IPO Connect” that could inject much-needed liquidity into the market and deepen international investors’ access to top-tier China assets. At every summer’s Lujiazui Forum, attended by China’s top financial... https://www.scmp.com/business/banking-finance/article/3358365/ipo-connect-pitched-hong-kongs-next-move-boost-finance-hub-role-hurdles-loom?utm_source=rss_feed https://www.scmp.com/business/banking-finance/article/3358365/ipo-connect-pitched-hong-kongs-next-move-boost-finance-hub-role-hurdles-loom?utm_source=rss_feed Thu, 25 Jun 2026 23:00:05 +0000 Themis Qi Themis Qi Momenta, a leading self-driving technology start-up in China, has become the latest domestic firm to receive regulatory approval from Beijing for listing in Hong Kong under an entity incorporated offshore. The nod comes over four months after the last green light given to an applicant with a similar structure. The vetting of firms organised in this manner was reportedly tightened to prevent asset outflows. Momenta Global Limited, an entity the start-up used to apply for an initial public... https://www.scmp.com/business/investor-relations/ipo-quote-profile/article/3358011/chinese-red-chip-start-granted-regulatory-approval-amid-rumoured-crackdown?utm_source=rss_feed https://www.scmp.com/business/investor-relations/ipo-quote-profile/article/3358011/chinese-red-chip-start-granted-regulatory-approval-amid-rumoured-crackdown?utm_source=rss_feed Tue, 23 Jun 2026 04:34:13 +0000 Julie Zhang Julie Zhang Cross-border biotech deals between China and the United States are becoming more complicated and could face a modest slowdown as Washington steps up efforts to restrict investment and technology transfers, according to industry analysts. “There will be more geopolitical scrutiny going forward. This scrutiny may lead to slightly fewer deals than without it,” said Diederik Stadig, senior healthcare economist at ING Research. Despite the growing regulatory hurdles, Stadig said the broader trend of... https://www.scmp.com/business/china-business/article/3357699/cross-border-biotech-deals-grow-more-complex-us-targets-china-investment-links?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3357699/cross-border-biotech-deals-grow-more-complex-us-targets-china-investment-links?utm_source=rss_feed Sun, 21 Jun 2026 01:30:08 +0000 Zhu Wenqian Zhu Wenqian Lenovo Group, the world’s largest personal-computer (PC) maker, plans to raise US$2 billion through a convertible-bond offering, with the proceeds earmarked to repurchase existing debt and buy back shares. The Hong Kong-listed company’s proposed zero-coupon convertible bonds will mature in 2033 and can be exchanged for 426.9 million shares at an initial conversion price of HK$36.70, or US$4.68 a share, according to a Hong Kong stock exchange filing on Wednesday. “Lenovo’s convertible bond... https://www.scmp.com/business/china-business/article/3357533/lenovo-targets-us2-billion-bond-repurchase-debt-amid-robust-ai-infrastructure-growth?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3357533/lenovo-targets-us2-billion-bond-repurchase-debt-amid-robust-ai-infrastructure-growth?utm_source=rss_feed Thu, 18 Jun 2026 07:27:56 +0000 Themis Qi Themis Qi Kaifeng Millennium City Park Inc., the operator of a theme park based on a famous Chinese painting dating back to the Northern Song dynasty, has submitted an initial public offering (IPO) application in Hong Kong, following similar moves by other mainland China non-tech plays recently. The company’s Millennium City Park in Kaifeng, Henan province, offers a physical, life-size recreation of Along the River During the Qingming (Ching Ming) Festival, it said in the prospectus it filed to the Hong... https://www.scmp.com/business/investor-relations/ipo-quote-profile/article/3357230/mainland-china-theme-park-operator-applies-listing-hong-kong?utm_source=rss_feed https://www.scmp.com/business/investor-relations/ipo-quote-profile/article/3357230/mainland-china-theme-park-operator-applies-listing-hong-kong?utm_source=rss_feed Tue, 16 Jun 2026 02:37:54 +0000 Enoch Yiu Enoch Yiu The liquidators of China Evergrande Group are in a legal battle with the city’s market regulator over its settlement agreement with PricewaterhouseCoopers (PwC) Hong Kong, claiming that the agreement leaves creditors HK$1 billion (US$128 million) worse off, according to a court document released on Monday. The writ filed with Hong Kong’s High Court seeks leave to apply for a judicial review of the Securities and Futures Commission’s (SFC) agreement with PwC Hong Kong and an order preventing the... https://www.scmp.com/business/china-business/article/3357194/china-evergrande-liquidators-seek-judicial-review-sfc-agreement-pwc-hong-kong?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3357194/china-evergrande-liquidators-seek-judicial-review-sfc-agreement-pwc-hong-kong?utm_source=rss_feed Mon, 15 Jun 2026 12:26:13 +0000 Julie Zhang Julie Zhang China’s biotech firms are pressing ahead with global expansion, a trend industry insiders describe as “irreversible”, even as Washington rolls out investment restrictions and national security measures aimed at slowing their advance. “The US has erected numerous regulatory and non-tariff barriers for Chinese companies seeking to enter the American market,” said Zhang Jun, co-head of the global healthcare group at Chinese investment bank Citic Securities, at the Hong Kong Exchanges and Clearing’s... https://www.scmp.com/business/china-business/article/3356778/chinas-biotech-industry-sees-global-expansion-unstoppable-despite-us-pressure?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3356778/chinas-biotech-industry-sees-global-expansion-unstoppable-despite-us-pressure?utm_source=rss_feed Thu, 11 Jun 2026 11:30:15 +0000 Themis Qi Themis Qi China’s electric vehicle (EV) king BYD said demand for its second-generation blade batteries currently outstrips existing capacity, as Chinese cars gain popularity around the globe. At the company’s annual general meeting in Shenzhen on Tuesday, chairman and president Wang Chuanfu told shareholders that its Blade Battery 2.0 and Flash Charging technology had received a warm response in domestic and overseas markets, but that battery cell production remained insufficient to meet demand. BYD was... https://www.scmp.com/business/china-evs/article/3356529/byd-eyes-sales-boost-fast-charging-battery-capacity-catch?utm_source=rss_feed https://www.scmp.com/business/china-evs/article/3356529/byd-eyes-sales-boost-fast-charging-battery-capacity-catch?utm_source=rss_feed Tue, 09 Jun 2026 11:07:32 +0000 Julie Zhang Julie Zhang For Beijing-based METiS TechBio CEO Lai Tsai-ta, ageing is comparable to bugs building up in a complex software system – it happens once errors begin to accumulate in the genetic code of human cells, such as their DNA sequences. “Those errors can be reprogrammed. It becomes possible to use AI to read, rewrite and reverse cells, or at least slow the ageing process,” Lai said in an interview with the South China Morning Post. The process could begin by fixing “immune cells, such as T cells, as... https://www.scmp.com/business/china-business/article/3356154/targeting-us610-billion-longevity-market-biotech-firms-race-reverse-ageing?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3356154/targeting-us610-billion-longevity-market-biotech-firms-race-reverse-ageing?utm_source=rss_feed Sat, 06 Jun 2026 00:00:20 +0000 Daisy Wu Daisy Wu Shenzhen-based AI engineer Sihan Wang recently decided to liquidate all holdings in his Futu Securities account, which he opened a year ago, citing concerns that escalating regulatory oversight could restrict his ability to manage overseas investments. “I would rather step back now than risk having my funds caught up in future restrictions,” Wang said. He is now considering shifting capital into mainland-listed gold products and mutual funds. Wang’s move reflects a broader squeeze on mainland... https://www.scmp.com/business/china-business/article/3356095/mainland-chinas-investors-face-new-hurdles-hong-kong-brokers-tighten-rules?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3356095/mainland-chinas-investors-face-new-hurdles-hong-kong-brokers-tighten-rules?utm_source=rss_feed Fri, 05 Jun 2026 08:47:54 +0000 Julie Zhang Julie Zhang Tiger Brokers reported a 17.5 per cent year-on-year jump in first-quarter operating profit in an announcement on Tuesday, without any mention of the looming punishment from China’s securities regulator over alleged unlicensed cross-border trading services. Tiger Brokers said its operating profit rose to US$47.6 million in the three months ended March 31, while revenue climbed 26.3 per cent from a year earlier to US$154.9 million. The growth was driven by a 536 per cent surge in Hong Kong trading... https://www.scmp.com/business/banking-finance/article/3355729/chinas-tiger-brokers-reports-strong-results-no-mention-trading-crackdown?utm_source=rss_feed https://www.scmp.com/business/banking-finance/article/3355729/chinas-tiger-brokers-reports-strong-results-no-mention-trading-crackdown?utm_source=rss_feed Tue, 02 Jun 2026 13:00:18 +0000 Julie Zhang Julie Zhang Akeso, whose drug ivonescimab was hailed as biotech’s “DeepSeek moment” amid US competition last year, announced better-than-expected clinical results showing it can treat a type of lung cancer commonly found in smokers, potentially expanding its approved uses. Analysts suggest it could become a backbone therapy in the US$20 billion global non-small cell lung cancer market and have revised their target prices upwards. The drug’s phase three trial found that ivonescimab reduced the risk of death... https://www.scmp.com/business/china-business/article/3355579/akeso-lung-cancer-drug-shines-trials-boosting-hopes-us20b-market?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3355579/akeso-lung-cancer-drug-shines-trials-boosting-hopes-us20b-market?utm_source=rss_feed Mon, 01 Jun 2026 10:49:08 +0000 Peggy Ye,Zhang Shidong Peggy Ye,Zhang Shidong Hong Kong Exchanges and Clearing (HKEX) has overhauled its Tech 100 Index, adding seven technology-focused companies and removing seven others, as Hong Kong’s benchmark providers face growing pressure to reflect the rapid rise of artificial intelligence stocks. The latest additions by Hong Kong’s bourse operator increase the benchmark’s exposure to areas such as autonomous driving, robotics, enterprise software and optical communications. The changes, which take effect on June 15, bring in... https://www.scmp.com/business/markets/article/3355329/hkex-revamps-tech-100-index-hong-kong-benchmark-struggles-keep-pace-ai-rally?utm_source=rss_feed https://www.scmp.com/business/markets/article/3355329/hkex-revamps-tech-100-index-hong-kong-benchmark-struggles-keep-pace-ai-rally?utm_source=rss_feed Fri, 29 May 2026 10:37:37 +0000 Julie Zhang Julie Zhang Home-grown innovative drugs make up most of the medicines China’s drug regulator has approved for sale so far this year, underscoring the country’s biotech boom. Of the 19 innovative drugs cleared by the National Medical Products Administration (NMPA), 15 came from domestic companies, according to the regulator’s website as of May 21. These include sonrotoclax, developed by global biopharmaceutical firm BeOne, for treating certain adult blood cancers. The regulator overhauled its approval... https://www.scmp.com/business/china-business/article/3355021/chinas-drug-regulator-clears-wave-home-grown-innovative-medicines-amid-biotech-boom?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3355021/chinas-drug-regulator-clears-wave-home-grown-innovative-medicines-amid-biotech-boom?utm_source=rss_feed Wed, 27 May 2026 13:00:08 +0000 Enoch Yiu,Daniel Ren Enoch Yiu,Daniel Ren Hong Kong is expected to remain among the top three initial public offering (IPO) markets worldwide this year, even though it will soon be dethroned by the US Nasdaq, which will host SpaceX’s jumbo flotation. Hong Kong Exchanges and Clearing’s (HKEX) main board is poised to lose its crown as the world’s largest market for IPOs when billionaire Elon Musk’s commercial aerospace unit is listed on the Nasdaq stock exchange, according to the prospectus filed by SpaceX in New York on Wednesday. The... https://www.scmp.com/business/banking-finance/article/3354406/hong-kong-set-be-ousted-nasdaq-worlds-biggest-ipo-market-still-top-3?utm_source=rss_feed https://www.scmp.com/business/banking-finance/article/3354406/hong-kong-set-be-ousted-nasdaq-worlds-biggest-ipo-market-still-top-3?utm_source=rss_feed Thu, 21 May 2026 13:00:15 +0000 Themis Qi Themis Qi Shares of Chinese aviation and aerospace parts supplier Shanghai Top Numerical Control Technology ended 80 per cent higher on its debut in Hong Kong on Wednesday, as investors continue to bet on the commercial aerospace sector. Top Numerical Control opened at HK$37 per share on its first day of trading, representing a 40.2 per cent premium to the offer price of HK$26.39. It reached as high as HK$48.40 in afternoon trade, before closing at HK$47.50. The Shanghai-based company issued 65.33 million... https://www.scmp.com/business/investor-relations/ipo-quote-profile/article/3354227/chinas-top-numerical-control-rides-investor-fervour-aerospace-80-ipo-gain?utm_source=rss_feed https://www.scmp.com/business/investor-relations/ipo-quote-profile/article/3354227/chinas-top-numerical-control-rides-investor-fervour-aerospace-80-ipo-gain?utm_source=rss_feed Wed, 20 May 2026 08:34:29 +0000 Julie Zhang Julie Zhang Shares of METiS TechBio surged 173 per cent on their Hong Kong debut on Wednesday as the AI-driven drug design start-up’s initial public offering drew strong demand from investors amid buoyant sentiment for AI-related stocks in the city. Its stocks traded at HK$28.68 at the open, climbing as high as HK$29.6 in the morning trading session before retreating to HK$23.8 at the close, up 126.67 per cent from the offering price. Co-founder and CEO of METiS TechBio, Lai Tsai-Ta, who obtained a PhD from... https://www.scmp.com/business/banking-finance/article/3353341/hong-kong-biotech-firm-uses-ai-produce-nano-rockets-deliver-life-saving-drugs?utm_source=rss_feed https://www.scmp.com/business/banking-finance/article/3353341/hong-kong-biotech-firm-uses-ai-produce-nano-rockets-deliver-life-saving-drugs?utm_source=rss_feed Wed, 13 May 2026 01:30:13 +0000 Themis Qi Themis Qi Chinese industrial robot maker Shenzhen Inovance Technology submitted an initial public offering (IPO) application in Hong Kong on Tuesday, joining a wave of mainland tech firms seeking capital from international investors. Founded in 2003, Inovance is seen as a cornerstone of China’s industrial automation sector. The company’s shares, listed on the Shenzhen Stock Exchange since 2010, closed at 61.36 yuan on Tuesday, giving it a market capitalisation of nearly 175.3 billion yuan (US$25.6... https://www.scmp.com/news/china-future-tech/robotics/article/3351738/chinese-industrial-robot-maker-inovance-joins-hong-kong-ipo-queue?utm_source=rss_feed https://www.scmp.com/news/china-future-tech/robotics/article/3351738/chinese-industrial-robot-maker-inovance-joins-hong-kong-ipo-queue?utm_source=rss_feed Tue, 28 Apr 2026 12:30:19 +0000 Yulu Ao Yulu Ao China’s solar giant Sungrow Power Supply has filed a fresh application to list in Hong Kong, reviving plans initiated last year, as a wave of mainland companies seeks offshore funding to support overseas expansion. The Shenzhen-listed solar inverter and energy storage system maker submitted its latest application proof to the Hong Kong stock exchange after an earlier filing in October lapsed, according to exchange disclosures late on Friday. Sungrow, one of the world’s largest suppliers of... https://www.scmp.com/business/china-business/article/3351515/chinas-solar-giant-sungrow-revives-hong-kong-ipo-plan-amid-rising-demand-clean-energy?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3351515/chinas-solar-giant-sungrow-revives-hong-kong-ipo-plan-amid-rising-demand-clean-energy?utm_source=rss_feed Mon, 27 Apr 2026 03:55:24 +0000 Julie Zhang Julie Zhang Eight mainland China-based companies – five of them biotech firms – passed listing hearings on the Hong Kong stock market in April, clearing the way for them to tap the city’s deep liquidity. The influx, including an AI-driven drug discovery firm, a driverless technology developer and a maker of industrial robots, comes as the China Securities Regulatory Commission (CSRC) has been pushing private firms to list in Hong Kong. The market regulator has required companies that established so-called... https://www.scmp.com/business/banking-finance/article/3351001/biotech-led-boom-8-china-firms-flock-hong-kongs-thriving-stock-market?utm_source=rss_feed https://www.scmp.com/business/banking-finance/article/3351001/biotech-led-boom-8-china-firms-flock-hong-kongs-thriving-stock-market?utm_source=rss_feed Wed, 22 Apr 2026 08:53:15 +0000 Daniel Ren Daniel Ren Hong Kong Exchanges and Clearing (HKEX) has proposed halving the cash settlement cycle for share trading as part of efforts to enhance market efficiency and liquidity. The city’s bourse operator said in a consultation paper on Friday that it aimed to implement a “T+1” system – under which trades are settled one day after the transaction – in the fourth quarter of 2027, replacing the existing “T+2” cycle. If adopted, the shortened cycle would apply to equities, exchange-traded products,... https://www.scmp.com/business/banking-finance/article/3350526/hkex-proposes-halving-share-settlement-cycle-bid-boost-hong-kongs-financial-profile?utm_source=rss_feed https://www.scmp.com/business/banking-finance/article/3350526/hkex-proposes-halving-share-settlement-cycle-bid-boost-hong-kongs-financial-profile?utm_source=rss_feed Fri, 17 Apr 2026 13:51:01 +0000 Themis Qi Themis Qi Shares of Chinese energy storage system (ESS) maker Sigenergy Technology jumped 103 per cent on their Hong Kong trading debut, as concerns surrounding energy security due to the conflict in the Middle East boost demand for renewable-energy solutions. The Shanghai-based company’s shares opened at HK$581, versus its offer price of HK$324.20. It climbed further and closed at HK$659.50. The firm raised HK$4.4 billion (US$560 million) from its initial public offering. On the grey market on Wednesday... https://www.scmp.com/business/investor-relations/ipo-quote-profile/article/3350260/sigenergy-jumps-83-hong-kong-debut-rising-energy-storage-demand?utm_source=rss_feed https://www.scmp.com/business/investor-relations/ipo-quote-profile/article/3350260/sigenergy-jumps-83-hong-kong-debut-rising-energy-storage-demand?utm_source=rss_feed Thu, 16 Apr 2026 05:23:05 +0000 Julie Zhang Julie Zhang Hong Kong initial public offerings (IPOs) are attracting strong international demand as global funds rebuild their exposure to China after years of underinvestment, according to Bonnie Chan Yiting, CEO of Hong Kong Exchanges and Clearing. The Hong Kong stock exchange was seeing “very good momentum on both the supply and demand sides” for IPOs, Chan told a panel discussion at the HSBC Global Investment Summit on Wednesday. On the “cornerstone front”, last year saw “a very strong pickup by... https://www.scmp.com/business/banking-finance/article/3350162/global-funds-fuel-hong-kong-ipo-rebound-investors-rebalance-china-portfolios-hkex?utm_source=rss_feed https://www.scmp.com/business/banking-finance/article/3350162/global-funds-fuel-hong-kong-ipo-rebound-investors-rebalance-china-portfolios-hkex?utm_source=rss_feed Wed, 15 Apr 2026 09:00:13 +0000 Themis Qi Themis Qi Shanghai-listed Huaqin, one of the world’s largest consumer electronics original design manufacturers (ODMs), kicked off a Hong Kong share sale on Wednesday, aiming to raise up to HK$4.55 billion (US$580 million). The electronics giant – the latest mainland-listed firm to tap Hong Kong’s stock market with Beijing’s backing – is offering 58.55 million shares, with 10 per cent earmarked for retail investors and the rest for international placement. The maximum offer price of HK$77.70 per share... https://www.scmp.com/business/investor-relations/ipo-quote-profile/article/3350132/huaqins-us580-million-hong-kong-share-sale-attracts-jpmorgan-and-ubs?utm_source=rss_feed https://www.scmp.com/business/investor-relations/ipo-quote-profile/article/3350132/huaqins-us580-million-hong-kong-share-sale-attracts-jpmorgan-and-ubs?utm_source=rss_feed Wed, 15 Apr 2026 06:00:51 +0000 Julie Zhang Julie Zhang US dollar-denominated funds could face more hurdles when investing in Chinese tech and biotech companies as Beijing adopts a stricter approach to companies seeking listings via offshore incorporated vehicles. Indicative of Chinese regulators’ caution in overseeing sensitive industries, industry sources say the move ensures that any sale of assets does not escape regulatory scrutiny. And for any offshore incorporated structures that are approved, the stock regulator requires listing applicants to... https://www.scmp.com/business/banking-finance/article/3349166/stricter-chinese-scrutiny-offshore-vehicles-blow-tech-and-biotech-ipo-candidates?utm_source=rss_feed https://www.scmp.com/business/banking-finance/article/3349166/stricter-chinese-scrutiny-offshore-vehicles-blow-tech-and-biotech-ipo-candidates?utm_source=rss_feed Tue, 07 Apr 2026 00:00:09 +0000 Enoch Yiu Enoch Yiu Hong Kong has retained its top position in terms of initial public offering (IPO) funds raised in the first quarter of this year but industry experts said the city could lose its lead to the US over the full year given the number of mega IPOs expected there, from OpenAI to Elon Musk’s SpaceX. A total of 37 companies raised about US$13.26 billion on the Hong Kong stock exchange’s main board in the three months ended March 31, according to data released on Tuesday by LSEG Data and Analytics. That... https://www.scmp.com/business/banking-finance/article/3348536/hong-kong-retains-global-ipo-crown-first-quarter-faces-us-mega-listings?utm_source=rss_feed https://www.scmp.com/business/banking-finance/article/3348536/hong-kong-retains-global-ipo-crown-first-quarter-faces-us-mega-listings?utm_source=rss_feed Tue, 31 Mar 2026 11:30:12 +0000 Julie Zhang,Daniel Ren Julie Zhang,Daniel Ren Biotech firm Hangzhou Diagens Biotechnology is banking on artificial intelligence-powered chromosome testing to drive profit growth following its Hong Kong listing, as China’s falling fertility rate spurs demand for assisted reproduction. “In China, many young people do not want to marry or have children, and by the time they decide to start a family, they need medical help to do so,” said Diagens’ founder and executive director Song Ning. “We are meeting an increasing number of couples every... https://www.scmp.com/business/banking-finance/article/3348335/chinese-company-use-ai-powered-chromosome-testing-boost-profits-and-fast-track-ivf?utm_source=rss_feed https://www.scmp.com/business/banking-finance/article/3348335/chinese-company-use-ai-powered-chromosome-testing-boost-profits-and-fast-track-ivf?utm_source=rss_feed Mon, 30 Mar 2026 02:45:34 +0000 Julie Zhang Julie Zhang Insilico Medicine has signed a potential multibillion-dollar deal with Eli Lilly to license out an early-stage drug pipeline and provide its artificial intelligence platform services in research and development collaborations. Under the agreement announced on Monday, US-headquartered, Hong Kong-listed Insilico will receive an upfront payment of US$115 million. The deal could have a total value of around US$2.75 billion tied to development, regulatory and commercial milestones, plus tiered... https://www.scmp.com/business/china-business/article/3348333/hong-kong-listed-insilico-medicine-signs-ai-drug-development-deal-eli-lilly?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3348333/hong-kong-listed-insilico-medicine-signs-ai-drug-development-deal-eli-lilly?utm_source=rss_feed Mon, 30 Mar 2026 01:24:48 +0000 Julie Zhang Julie Zhang Beijing Tong Ren Tang Healthcare Investment, a provider of healthcare services based on traditional Chinese medicine, postponed its Hong Kong initial public offering (IPO) on Friday amid tepid investor demand for its shares. The delay is the first of its kind during the current IPO boom. New share offerings in the city raised about US$11.64 billion as of March 18 this year, up 385 per cent from about US$2.4 billion a year earlier, according to LSEG Data & Analytics. Tong Ren Tang was one of six... https://www.scmp.com/business/banking-finance/article/3348101/tong-ren-tang-healthcare-unit-pulls-hong-kong-ipo-scheduled-monday?utm_source=rss_feed https://www.scmp.com/business/banking-finance/article/3348101/tong-ren-tang-healthcare-unit-pulls-hong-kong-ipo-scheduled-monday?utm_source=rss_feed Fri, 27 Mar 2026 06:30:18 +0000 Enoch Yiu Enoch Yiu Hong Kong Investment Corporation (HKIC), the government’s investment arm, has teamed up with venture capital firm Gobi Partners and the University of Hong Kong (HKU) to launch a fund on Tuesday to invest in technology start-ups spun off from the university’s research breakthroughs, according to an HKIC statement. Gobi-HKU Fund I made two investments at its launch: Manifold Tech, which develops spatial intelligence for robotics, and AilsynBio, which focuses on artificial intelligence-driven drug... https://www.scmp.com/business/banking-finance/article/3347689/hkic-gobi-partners-and-hku-team-fund-backing-university-research-start-ups?utm_source=rss_feed https://www.scmp.com/business/banking-finance/article/3347689/hkic-gobi-partners-and-hku-team-fund-backing-university-research-start-ups?utm_source=rss_feed Tue, 24 Mar 2026 07:21:49 +0000